Episode 3: Our Language As the stock market continues to soar, jazz is everywhere in America, and now, for the first time soloists and singers take center stage, transforming the music with their ...
BRUCE C COZADD, the Chairman & CEO of $JAZZ, sold 1,500 shares of the company on 02-03-2025 for an estimated $183,465. We received data on the trade from a recent SEC ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report), with a price ...
Blue Trust Inc. raised its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 73.7% in the fourth quarter, ...
Rhumbline Advisers raised its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 1.1% in the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results